Filter By Unselect All

Sub Category Unselect See All

Country Unselect See All

Companies Unselect See All

Selected Filter(s): Reset All

  • Category
  • Reset
  • Sub Category
  • Reset
  • Country
  • Reset

Bioequivalence Studies / Studies I-IV Phase

Analytical >> BioAnalytical Services >> Overview

Quinta Analytica conducts Phase I clinical trials, namely BA and BE in healthy volunteers efficiently at its dedicated ~1000 square meters clinical department comprising 64 beds in two independent units.

Bioanalytical Services

Analytical >> BioAnalytical Services >> Overview

Cambridge Biomedical is positioned to provide support throughout the drug development process, from preclinical through phase IV trials and post-market commercial testing. We are established experts in complex and custom biomarker assay development, assay validation, and specimen analysis.

In-Vitro Bioequivalence studies

Analytical >> BioAnalytical Services >> Overview

Our integrated product development services help biopharmaceutical companies shorten time to market, manage risk and access new global markets to maximize portfolio value.

Bioanalytical Testing

Analytical >> BioAnalytical Services >> Overview

We offer method development, validation and specimen analysis using state-of-the-art laboratory equipment and techniques, including Ultra Performance Liquid Chromatography Mass Spectrometry (UPLC/MS/MS) and liquid and gas chromatography techniques.

Bioavailability / Bioequivalence studies in Healthy and Patient Population

Analytical >> BioAnalytical Services >> Overview

Our integrated product development services help biopharmaceutical companies shorten time to market, manage risk and access new global markets to maximize portfolio value.

Protein Expression and Purification (Case by Case Basis)

Analytical >> BioAnalytical Services >> Overview

Shantani's portfolio of services based on chemical-proteomics technologies helps you identify & validate drug targets; thus de-risking molecules and supporting crucial GO / NO-GO decisions throughout the drug discovery process.

Clinical Bioanalysis (Bioanalytical)

Analytical >> BioAnalytical Services >> Overview

Our integrated product development services help biopharmaceutical companies shorten time to market, manage risk and access new global markets to maximize portfolio value.

Bio-Analytical Service

Analytical >> BioAnalytical Services >> Overview

Sequent Research is a leading Contract Research Organization that specializes in Analytical and Bio Analytical Services to support the API, Pharmaceutical, Personal Care, Institutional and Nutraceutical companies.

Bioanalytical Services

Analytical >> BioAnalytical Services >> Overview

Through Diteba, we offer method development, validation and specimen analysis using state-of-the-art equipment and techniques. These include Ultra Performance Liquid Chromatography Mass Spectrometry (UPLC/MS/MS) as well as liquid and gas chromatography.

Automated Lab Reactors

Analytical >> BioAnalytical Services >> Overview

Dedicated laboratory and infrastructure addressing the needs of clients with highly potent synthetic molecules including containment solutions for beta-lactams.

When developing a new drug, there is a good chance there won’t be a well-established method in place for analytically testing the physical and chemical properties of a potential API. Also, when existing compounds are used together in a new formulation, analytical method development might be necessary in order to test the drugs’ interactions with each other, the formulation excipients or biological fluids. Whether you need help with dissolution method development or for analytical testing using HPLC, LCMS or any number of immunoassays, there are many companies that provide analytical method development services. In addition to method development and validation services, many of these companies have qualified scientific staff to perform analytical tests once the methods have been developed and validated. CRO’s with experienced analytical staff specializing in analytical method development and validation for early to late stage pharmaceuticals and drug development processes. Also have experience with over the counter (OTC) and neutraceutical products. They develop drug substance and drug product analytical methods from scratch, improve and expand existing methods, and even troubleshoot and fix problematic analytical methods. Our analytical method validation will be appropriate for your drug development program and comply with ICH guidelines. Phase of drug development is very important for efficient analytical method development and analytical method validation. Our analytical approach means our methods are “fit for purpose”. Thus, methods for IND submission during phase I support are scientifically sound, but challenged in validation to a lesser extent than a phase III product methods. Analytical method development involves Stability-indicating analytical methods, Drug substance, Drug product (tablets, capsules, syrups, etc.), and Forced degradation studies Impurities, Chiral method development, Stability testing in support of first-in-human studies, Content uniformity method development, validation and testing, Dissolution method development, validation and testing, Blinded comparator agent testing, Analytical method troubleshooting, Analytical method optimization, Extractables, leachables, Reference GMP regulations and standards, Cleaning verification guidelines and method development, validation, Technology transfer methods etc. Analytical method transfers (AMTs) are typically performed as a precursor to a critical step in the drug-development timeline, such as bringing on a new manufacturing facility, release testing of clinical or commercial material, or initiating stability studies at a quality-control laboratory. AMTs document that a new internal or external testing laboratory is qualified on the previously validated analytical method in order to generate current Good Manufacturing Practices (cGMP)-compliant data. According to the U.S. Food and Drug Administration’s (FDA) Analytical Procedures and Methods Validation for Drugs and Biologics: Guidance for Industry, “analytical procedures should be described in sufficient detail to allow a competent analyst to reproduce the necessary conditions and obtain results within the proposed acceptance criteria.” 1 Although this statement implies that the process should be relatively straightforward, it does not mean AMTs are as simple as providing the analytical method to the new testing site and assuming it will be able to execute the method successfully. Differences in instrumentation, techniques, procedures and even interpretations of an analytical procedure can lead to preventable AMT failures.

ABOUT
THE PAGE

COLLAPSE

PharmaCompass